Robyn Catlett-Falcone
- Oncology top 2%
- Molecular Biology top 10%
- Immunology top 5%
- Pathology and Forensic Medicine top 2%
- Cancer Research top 5%
- Co-authors
- Richard JoveMarc M. OshiroWilliam S. DaltonJames TurksonAlexander LevitzkiTerry H. LandowskiLynn C. MoscinskiGabriel Núñez
- Topics
- Cytokine Signaling Pathways and Interactions (8 papers)Cancer Mechanisms and Therapy (3 papers)Immune Cell Function and Interaction (3 papers)
- Partner nations
- United StatesIsraelSpain
In The Last Decade
Robyn Catlett-Falcone
8 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.6k
- Molecular Biology 1.3k
- Immunology 684
- Pathology and Forensic Medicine 612
- Cancer Research 368
Countries citing papers authored by Robyn Catlett-Falcone
This map shows the geographic impact of Robyn Catlett-Falcone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Catlett-Falcone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Catlett-Falcone more than expected).
Fields of papers citing papers by Robyn Catlett-Falcone
This network shows the impact of papers produced by Robyn Catlett-Falcone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Catlett-Falcone. The network helps show where Robyn Catlett-Falcone may publish in the future.
Co-authorship network of co-authors of Robyn Catlett-Falcone
This figure shows the co-authorship network connecting the top 25 collaborators of Robyn Catlett-Falcone. A scholar is included among the top collaborators of Robyn Catlett-Falcone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn Catlett-Falcone. Robyn Catlett-Falcone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone. | 40 |
| 2 | Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionbreakdown → | 505 |
| 3 | Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells. | 39 |
| 4 | 1 | |
| 5 | 1 | |
| 6 | Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cellsbreakdown → | 1408 |
| 7 | 152 | |
| 8 | Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. | 274 |
About Robyn Catlett-Falcone
Robyn Catlett-Falcone is a scholar working on Oncology, Pharmacology and Pathology and Forensic Medicine, having authored 8 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), Cancer Mechanisms and Therapy (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (1.6k citations), Pathology and Forensic Medicine (612 citations) and Immunology (684 citations). Robyn Catlett-Falcone has collaborated with scholars based in United States, Israel and Spain. Frequent co-authors include Richard Jove, Marc M. Oshiro, William S. Dalton, James Turkson, Alexander Levitzki, Terry H. Landowski, Lynn C. Moscinski, Gabriel Núñez, Rocco Savino and Gennaro Ciliberto. Their work appears in journals such as Journal of Clinical Investigation, Immunity and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.